The DOI matches its Crossref record.
Vancomycin Added to Empirical Combination Antibiotic Therapy for Fever in Granulocytopenic Cancer Patients
Abstract
A total of 747 febrile granulocytopenic patients with cancer were randomized to receive ceftazidime plus amikacin (CA)with or without vancomycin (V) as initial empirical therapy. Single gram-positive bacteremias responded in 29(43%)of68 patients treated with CA and in 48(72%) of 67 treated with CAV (P = .(01). For single gram-negative bacteremias and clinically documented and possible infections the response rates of CA and CAV were 80% and 63%(P = .17), 55% and 75%(P = .009), and 74% and 81% (P = .16), respectively. However, for patients with grampositive bacteremia and for all other patients, there were no differences by treatment regimens in the proportion of febrile patients on each trial day (P = .85, P = .82, respectively) or in the duration of fever (P = .22, P = 93, respectively). Moreover, no patient with gram-positive bacteremia died during the first 3 days of true empirical therapy. Antibiotic-associated nephrotoxicity was more frequent in patients treated with vancomycin (6%vs. 2%, P =.02). These results do not support the empirical addition of vancomycin to initial antibiotic therapy in cancer patients with fever and granulocytopenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602
Management of Fever in Patients with Cancer and Treatment-Induced Neutropenia
Wood, A. J. J., & Pizzo, P. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305063281808 · Cited by 838
Metadata
- Authors
- European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group, & National Cancer Institute of Canada-Clinical Trials Group
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-05-01
- Volume
- 163
- Issue
- 5
- Pages
- 951-958
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W4238546275
- Cited by
- 246
- References
- 0
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vancomycin Added to Empirical Combination Antibiotic Therapy for Fever in Granulocytopenic Cancer Patients. https://app.cochat.ai/papers/10.1093/infdis/163.5.951
- The paper
- European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group, & National Cancer Institute of Canada-Clinical Trials Group. (1991). Vancomycin Added to Empirical Combination Antibiotic Therapy for Fever in Granulocytopenic Cancer Patients. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/163.5.951
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.